214 related articles for article (PubMed ID: 29737218)
1. The current situation and challenges of screening for and treating hepatitis B in sub-Saharan Africa.
Béguelin C; Fall F; Seydi M; Wandeler G
Expert Rev Gastroenterol Hepatol; 2018 Jun; 12(6):537-546. PubMed ID: 29737218
[TBL] [Abstract][Full Text] [Related]
2. Liver transplantation for hepatitis B virus: Decreasing indication and changing trends.
Al-Hamoudi W; Elsiesy H; Bendahmash A; Al-Masri N; Ali S; Allam N; Al Sofayan M; Al Bahili H; Al Sebayel M; Broering D; Saab S; Abaalkhail F
World J Gastroenterol; 2015 Jul; 21(26):8140-7. PubMed ID: 26185387
[TBL] [Abstract][Full Text] [Related]
3. NIH consensus development statement on management of hepatitis B.
Belongia EA; Costa J; Gareen IF; Grem JL; Inadomi JM; Kern ER; McHugh JA; Petersen GM; Rein MF; Sorrell MF; Strader DB; Trotter HT
NIH Consens State Sci Statements; 2008 Oct 22-24; 25(2):1-29. PubMed ID: 18949020
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of liver cirrhosis in individuals with hepatitis B virus infection in sub-Saharan Africa: Systematic review and meta-analysis.
Surial B; Wyser D; Béguelin C; Ramírez-Mena A; Rauch A; Wandeler G
Liver Int; 2021 Apr; 41(4):710-719. PubMed ID: 33220137
[TBL] [Abstract][Full Text] [Related]
5. Treatment of HBV related cirrhosis.
van Bömmel F; Berg T
Liver Int; 2013 Feb; 33 Suppl 1():176-81. PubMed ID: 23286862
[TBL] [Abstract][Full Text] [Related]
6. Viral Hepatitis: Knowledge and Treatments for Hepatitis B and C Virus and Associated Transplantation and Neoplasia.
Sherman KE; Shah VH
Gastroenterology; 2018 Feb; 154(3):453-456. PubMed ID: 29154778
[No Abstract] [Full Text] [Related]
7. Effects of antiviral therapy in patients with chronic hepatitis B and cirrhosis.
Okada M; Enomoto M; Kawada N; Nguyen MH
Expert Rev Gastroenterol Hepatol; 2017 Dec; 11(12):1095-1104. PubMed ID: 28752768
[TBL] [Abstract][Full Text] [Related]
8. Occult hepatitis B virus infection is not associated with disease progression of chronic hepatitis C virus infection.
Cho J; Lee SS; Choi YS; Jeon Y; Chung JW; Baeg JY; Si WK; Jang ES; Kim JW; Jeong SH
World J Gastroenterol; 2016 Nov; 22(42):9427-9436. PubMed ID: 27895431
[TBL] [Abstract][Full Text] [Related]
9. [Viral Hepatitis B: clinical, paraclinical and evolutionary features within the Hepatogastroenterology Department at the Aristide Le Dantec Hospital: about 728 cases].
Diallo S; Bassène ML; Gueye MN; Thioubou MA; Dia D; Mbengue M; Diouf ML
Pan Afr Med J; 2018; 31():82. PubMed ID: 31011383
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B in sub-Saharan Africa: strategies to achieve the 2030 elimination targets.
Spearman CW; Afihene M; Ally R; Apica B; Awuku Y; Cunha L; Dusheiko G; Gogela N; Kassianides C; Kew M; Lam P; Lesi O; Lohouès-Kouacou MJ; Mbaye PS; Musabeyezu E; Musau B; Ojo O; Rwegasha J; Scholz B; Shewaye AB; Tzeuton C; Sonderup MW;
Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):900-909. PubMed ID: 29132759
[TBL] [Abstract][Full Text] [Related]
11. Perioperative reactivation of hepatitis B virus replication in patients undergoing partial hepatectomy for hepatocellular carcinoma.
Huang L; Li J; Lau WY; Yan J; Zhou F; Liu C; Zhang X; Shen J; Wu M; Yan Y
J Gastroenterol Hepatol; 2012 Jan; 27(1):158-64. PubMed ID: 21871026
[TBL] [Abstract][Full Text] [Related]
12. Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma.
Lu SN; Wang JH; Liu SL; Hung CH; Chen CH; Tung HD; Chen TM; Huang WS; Lee CM; Chen CC; Changchien CS
Cancer; 2006 Nov; 107(9):2212-22. PubMed ID: 17019738
[TBL] [Abstract][Full Text] [Related]
13. The progress and prospects of routine prophylactic antiviral treatment in hepatitis B-related hepatocellular carcinoma.
Jiang E; Shangguan AJ; Chen S; Tang L; Zhao S; Yu Z
Cancer Lett; 2016 Sep; 379(2):262-7. PubMed ID: 26272181
[TBL] [Abstract][Full Text] [Related]
14. Natural history of chronic hepatitis B REVEALed.
Chen CJ; Yang HI
J Gastroenterol Hepatol; 2011 Apr; 26(4):628-38. PubMed ID: 21323729
[TBL] [Abstract][Full Text] [Related]
15. Host immunity influences disease progression and antiviral efficacy in humans infected with hepatitis B virus.
Wang FS; Zhang Z
Expert Rev Gastroenterol Hepatol; 2009 Oct; 3(5):499-512. PubMed ID: 19817672
[TBL] [Abstract][Full Text] [Related]
16. Impact of long-term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B.
Kim WR; Loomba R; Berg T; Aguilar Schall RE; Yee LJ; Dinh PV; Flaherty JF; Martins EB; Therneau TM; Jacobson I; Fung S; Gurel S; Buti M; Marcellin P
Cancer; 2015 Oct; 121(20):3631-8. PubMed ID: 26177866
[TBL] [Abstract][Full Text] [Related]
17. Current clinical evidence for nucleos(t)ide analogues in patients with HBV-related hepatocellular carcinoma.
Yu Y; Ai J; Zhang W
Expert Rev Gastroenterol Hepatol; 2017 Oct; 11(10):925-937. PubMed ID: 28661190
[TBL] [Abstract][Full Text] [Related]
18. Changes in serum levels of HBV DNA and alanine aminotransferase determine risk for hepatocellular carcinoma.
Chen CF; Lee WC; Yang HI; Chang HC; Jen CL; Iloeje UH; Su J; Hsiao CK; Wang LY; You SL; Lu SN; Chen CJ;
Gastroenterology; 2011 Oct; 141(4):1240-8, 1248.e1-2. PubMed ID: 21703214
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus and human immunodeficiency virus co-infection in sub-Saharan Africa: a call for further investigation.
Burnett RJ; François G; Kew MC; Leroux-Roels G; Meheus A; Hoosen AA; Mphahlele MJ
Liver Int; 2005 Apr; 25(2):201-13. PubMed ID: 15780040
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma is associated with an increased risk of hepatitis B virus recurrence after liver transplantation.
Faria LC; Gigou M; Roque-Afonso AM; Sebagh M; Roche B; Fallot G; Ferrari TC; Guettier C; Dussaix E; Castaing D; Brechot C; Samuel D
Gastroenterology; 2008 Jun; 134(7):1890-9; quiz 2155. PubMed ID: 18424269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]